A Study to Describe the Real-world Effectiveness, Safety and Patterns of Use of Dupilumab in Patients With Chronic Spontaneous Urticaria
Clinical trial NCT07316114 · TERMINATED
Trial details
- NCT number
- NCT07316114
- Sponsor
- Sanofi
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2026-03-18
- Primary completion
- 2026-06-02
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.